Back to search

Spain· ES:61529

FOSITENS PLUS 20 mg / 12,5 mg COMPRIMIDOS

A medicinal product containing fosinopril + hidroclorotiazida, registered in Spain by Bausch Health Ireland Limited.

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedFOSITENS PLUS 20 mg / 12,5 mg COMPRIM…ATC—REGISTER NO.ES:61529PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
fosinopril + hidroclorotiazida
Manufacturer
Bausch Health Ireland Limited
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cima_codigo
    661225
    28
    EUR 9.82
  • cima_codigo
    671685
    28
    EUR 9.82

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fosinopril + hidroclorotiazida in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fosinopril + hidroclorotiazida products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Fosicomb, Fosinopril-Natrium/Hct Actavis
  • Bulgaria · Монозид
  • Czechia · Monace Combi
  • Estonia · Fosinopril Hct Actavis
  • France · Fosinopril Hydrochlorothiazide Arrow, Fosinopril/Hydrochlorothiazide Arrow Lab
  • Hungary · Duopril, Fosicard Plus
  • Italy · Fosicombi, Fosinopril E Idroclorotiazide Doc Generici
  • Lithuania · Fosinopril Hct Actavis
  • Latvia · Fosinopril Hct Actavis
  • Malta · Fosinopril + Hydrochlorothiazide Aurobindo
  • Netherlands · Fosinoprilnatrium/Hydrochloorthiazide Aurobindo
  • Portugal · Fosinopril + Hidroclorotiazida Aurobindo, Fosinopril + Hidroclorotiazida Aurovitas
  • Slovenia · Monopril Plus
  • Slovakia · Monozide

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b89926a3-6285-462c-b01f-cce8a2615452
GET /v1/drugs/b89926a3-6285-462c-b01f-cce8a2615452?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":867708000000}",
  "nregistro": "61529",
  "substance": "fosinopril + hidroclorotiazida"
}

See everything about fosinopril + hidroclorotiazida.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.